| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |